Anguraj Sadanandam
TitleCited byYear
The consensus molecular subtypes of colorectal cancer
J Guinney, R Dienstmann, X Wang, A De Reyničs, A Schlicker, ...
Nature medicine 21 (11), 1350-1356, 2015
15572015
Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy
EA Collisson, A Sadanandam, P Olson, WJ Gibb, M Truitt, S Gu, J Cooc, ...
Nature medicine 17 (4), 500, 2011
7562011
A colorectal cancer classification system that associates cellular phenotype and responses to therapy
A Sadanandam, CA Lyssiotis, K Homicsko, EA Collisson, WJ Gibb, ...
Nature medicine 19 (5), 619, 2013
6722013
A community effort to assess and improve drug sensitivity prediction algorithms
JC Costello, LM Heiser, E Georgii, M Gönen, MP Menden, NJ Wang, ...
Nature biotechnology 32 (12), 1202, 2014
3872014
Subtype and pathway specific responses to anticancer compounds in breast cancer
LM Heiser, A Sadanandam, WL Kuo, SC Benz, TC Goldstein, S Ng, ...
Proceedings of the National Academy of Sciences 109 (8), 2724-2729, 2012
3822012
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer
A Kapoor, W Yao, H Ying, S Hua, A Liewen, Q Wang, Y Zhong, CJ Wu, ...
Cell 158 (1), 185-197, 2014
3702014
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
G Vlachogiannis, S Hedayat, A Vatsiou, Y Jamin, J Fernández-Mateos, ...
Science 359 (6378), 920-926, 2018
2402018
Chemokines in tumor angiogenesis and metastasis
S Singh, A Sadanandam, RK Singh
Cancer and Metastasis Reviews 26 (3-4), 453-467, 2007
1852007
A community computational challenge to predict the activity of pairs of compounds
M Bansal, J Yang, C Karan, MP Menden, JC Costello, H Tang, G Xiao, ...
Nature biotechnology 32 (12), 1213, 2014
1492014
Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis
S Singh, A Sadanandam, KC Nannuru, ML Varney, R Mayer-Ezell, ...
Clinical Cancer Research 15 (7), 2380-2386, 2009
1302009
CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion
S Singh, KC Nannuru, A Sadanandam, ML Varney, RK Singh
British journal of cancer 100 (10), 1638-1646, 2009
1112009
The expression level of HJURP has an independent prognostic impact and predicts the sensitivity to radiotherapy in breast cancer
Z Hu, G Huang, A Sadanandam, S Gu, ME Lenburg, M Pai, N Bayani, ...
Breast cancer research 12 (2), R18, 2010
952010
Cathepsin G Enhances Mammary Tumor–Induced Osteolysis by Generating Soluble Receptor Activator of Nuclear Factor-κB Ligand
TJ Wilson, KC Nannuru, M Futakuchi, A Sadanandam, RK Singh
Cancer research 68 (14), 5803-5811, 2008
822008
Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis
A Sadanandam, EG Rosenbaugh, S Singh, M Varney, RK Singh
Microvascular research 79 (1), 1-9, 2010
792010
Reconciliation of classification systems defining molecular subtypes of colorectal cancer: interrelationships and clinical implications
A Sadanandam, X Wang, F de Sousa E Melo, JW Gray, L Vermeulen, ...
Cell cycle 13 (3), 353-357, 2014
732014
A cross-species analysis in pancreatic neuroendocrine tumors reveals molecular subtypes with distinctive clinical, metastatic, developmental, and metabolic characteristics
A Sadanandam, S Wullschleger, CA Lyssiotis, C Grötzinger, S Barbi, ...
Cancer discovery 5 (12), 1296-1313, 2015
672015
Colorectal cancer subtyping consortium (CRCSC) identification of a consensus of molecular subtypes.
R Dienstmann, J Guinney, M Delorenzi, A De Reynies, P Roepman, ...
Journal of Clinical Oncology 32 (15_suppl), 3511-3511, 2014
662014
High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis
A Sadanandam, ML Varney, S Singh, AE Ashour, N Moniaux, S Deb, ...
International journal of cancer 127 (6), 1373-1383, 2010
552010
Transforming growth factor‐β signaling at the tumor–bone interface promotes mammary tumor growth and osteoclast activation
M Futakuchi, KC Nannuru, ML Varney, A Sadanandam, K Nakao, K Asai, ...
Cancer science 100 (1), 71-81, 2009
522009
Small interfering RNA‐mediated CXCR1 or CXCR2 knock‐down inhibits melanoma tumor growth and invasion
S Singh, A Sadanandam, ML Varney, KC Nannuru, RK Singh
International journal of cancer 126 (2), 328-336, 2010
512010
The system can't perform the operation now. Try again later.
Articles 1–20